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Sixteen patients with acute myocardial infarction under-
went treatment with streptokinase up to 3 hours after
the onset of chest pain. Nine patients (group I) received
streptokinase within I hour of the onset of pain, and
seven patients (group II) received it within 2 to 3 hours.
All underwent multigated radionuclide ventriculog-
raphy after streptokinase therapy and I week later. Per-
cutaneous transluminal coronary angioplasty of the in-
farct artery was performed within 24 hours in all patients.
An effort-limited treadmill stress test was performed
before discharge. There was no mortality or serious com-
plication.
Mean peak total creatine kinase was521 ± 289 mU/ml
in group I, and 1,614 ± 709 mUlml in group II (p <
Several studies (1-4) have recently shown that myocardial
salvage and a reduction of mortality after thrombolysis for
evolving myocardial infarction are time dependent. Earlier
reperfusion was associated with a greater improvement in
ventricular function. Rentrop et al. (5) described a reper-
fusion time of 4 hours as the cutoff point for significant
salvage and others (3,6,7) suggested 3 or 2 hours. Koren
et al. (8), in a recent study, instituted streptokinase therapy
in a mobile intensive care unit and reported better preser-
vation of left ventricular function in patients receiving the
therapy within 90 minutes after the onset of symptoms. In
addition, the importance of early coronary angioplasty in
promoting further functional improvement of the myocar-
dium was recently suggested (9,10).
We present our experience in a carefully studied group
of 16 patients, 9 of whom underwent thrombolytic therapy
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0.05). The mean initial left ventricular ejection fraction
was 47 ± II % in group I and 37 ± 10% in group II.
After early angioplasty (within 24 hours) and at 1 week
recovery, left ventricular ejection fraction increased to
53 ± 9% in group I (p < 0.05) and to 40 ± 7% in
group II (p =NS). Seven of the nine patients in group
I had normal radionuclide ventriculograms at discharge
compared with none of the seven patients in group II.
Thrombolytic therapy administered less than 1 hour after
the onset of symptoms of acute myocardial infarction
followed by angioplasty of the infarct artery results in
preservation of left ventricular function, whereas ther-
apy given after 2 hours has only a limited effect.
(J Am Coil Cardiol /987;9:608-14)
within less than I hour from the onset of symptoms, and
the other 7 within 2 to 3 hours. All patients underwent
coronary angioplasty of the infarct-related artery. and their
clinical, radionuclide and cardiac catheterization data are
reported.
Methods
Selection of patients. From January to December 31,
1985, 33 patients received streptokinase therapy for acute
evolving myocardial infarction. Of these, nine patients were
given the thrombolytic therapy less than I hour after and
seven between 2 and 3 hours after the onset of symptoms.
These 16 patients (Table I) who were admitted to the in-
tensive coronary care unit at the Tel-Aviv Medical Center
met the following criteria: all were younger than 70 years
(range 33 to 64) and presented with severe, typical ischemic
chest pain, which lasted longer than 15 minutes and did not
respond to sublingual isosorbide dinitrate (5 mg) and ni-
fedipine (10 mg). There was at least 2 mm ST segment
elevation in three electrocardiographic leads, and the pa-
tients had no contraindication to streptokinase administra-
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Case
2
3
4
5
6
7
8
9
Mean ± SD
10
II
12
13
14
15
16
Mean ± SD
Age (yr)
&Sex
64M
60M
38M
38M
38M
57M
57M
63M
55M
52 .±. II
42M
57M
50M
43M
53F
47M
33F
46 .... 8
Site of MI
Group I
Inlerior
Anterior
Anterior
Inferior
Inferior
Anteroxeptal
Inferior
Anterior
Infenor
4 of 9 Antenor
Group II
Inferior
Anterior
Inferior
Lateral
Antenor
Lateral
Anterior
" of 7 Anterior
Old MI
Anterior
Lateral
Angina
+
+
t
CHF
There were no significant differences between groups with regard to age. CHF = conge-rive heart failure; F ~ female; M male; MI = myocardial
infarction; t - present; - ~ absent.
tion. All patients received intravenousstreptokinasetherapy;
they underwent two radionuclide studies, coronary angi-
ography, left ventriculography and .. infarct artery" angio-
plasty as well as predischarge exercise testing, Seventeen
additional patients were excluded from this report because
they received thrombolytic therapy either I to 2 hours or
more than 3 hours after the onset of ischemic pain, or they
did not complete this protocol.
Treatment protocol. Before the institution of therapy,
a 12 lead electrocardiogram was recorded and blood samples
were taken for a complete blood count, prothrombin time,
partial thromboplastin time and determination of serum lev-
els of total creatine kinase, glutamic oxaloacetic transami-
nase and lactic dehydrogenase. Each patient received 5,000
IV of heparin intravenously and a 500 mg bolus of hydro-
cortisone, followed by 750,000 units of streptokinase di-
luted in 50 ml of 5% dextrose in water solution, over a
period of 20 to 30 minutes. A 12 lead electrocardiogram
and blood samples for total creatine kinase were taken every
hour for 4 hours and every 4 hours for 24 hours. After 12
hours, systemic heparinization was achieved using a con-
tinuous infusionof heparin (1,000 IV/h). The patients under-
went radionuclide angiographic evaluation, cardiac cathe-
terization and angioplasty within 24 hours, and were then
followed up for 8 days in the intermediate coronary care
unit.
Radionuclide evaluation. A multigatedequilibrium blood
pool scan with 20 to 25 mCi in vivo labeled technetium-
99m red blood cells was performed in all patients within
24 hours after streptokinase infusionand immediatelybefore
cardiac catheterization. A secondscan was performed7 days
later. The left ventricular ejection fraction was determined
in the 45° left anterior oblique projection with a gamma
camera and a dedicated computer (Elscint Apex415) equipped
with a low energy collimator, from a background-corrected
left ventricular time-activity curve, as previously described
(\ I).
Coronary and ventricular angiography. Coronary an-
giography was performed within24 hours after streptokinase
therapy, using the Judkins transfemoral technique. The
coronary artery that was assumed to be uninvolved was
initially visualized by selective angiography, followed by
visualization of the artery supplying the infarct zone as
localized from the electrocardiogram. The site of the ste-
noses was recorded according to the Coronary Artery Sur-
gery Study coronary anatomy map (12). Left ventriculog-
raphy wasperformed in the 30°rightanterior oblique position.
Coronary angioplasty. Percutaneous angioplasty was
performed as described by Griintziget al. (\3) using Grunt-
zig (Shneider) and Simpson-Roberts (ACS) balloon cath-
eters and a steerable guide system. Only critical (>70%)
stenoses of the infarct artery were dilated.
Statistical methods. The distribution of variables was
compared within the same group with the paired student t
test, and when comparing two groups the unpaired t test
method was used. Data are presented as mean values ±
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Table 2. Electrocardiographic and Peak Serum Enzyme Changes
2
3
4
5
6
8
9
Mean -+: SO
10
II
12
13
14
15
16
Mean ± SO
p Value
Time to
Q Wave
Time to
Time to Peak CK Peak Before After Lead, With lsoelectric
SK (min) (lU/ml) (hours) SK SK ST t Baseline
Group I
15 697 8 1I,IIl,aVF II,1ll,aVF 2
15 213 4 VI to V, 2
15 341 4 VI to V, 4
15 683 10 I1,111 .aVF 1I,IIl,aVF 2
30 958 4 1I,lIl,aVF 2
30 251 6 VI to V, VI to V, VI to V, Persist.
60 360 8 VI to V, 2
45 294 8 II.m.svr 2
32 ± 19 521 -t 289 7.1 + 2.8 5 of 9 3 ± 1.5
Group II
120 654 12 1I,1I1,aVF 1I,II1,aVF 4
120 2,813 12 VI to V, VI to V, 12
120 1,640 6 1I,II1,aVF 1l,IIl,aVF 4
120 1,738 10 I. V, to V,,- l,aVL,V"V" 3
220 878 8 VI to V, VI to V" 2
220 1,632 12 V"V" l,aVL,V"V" 3
ISO 1,940 12 V"V" l,aVL,V"V" 4
153 ± 47 1,614 + 709 10.2 j- 2.4 7 of 7 4.8 ± 3.6
<0.01 <0.05 NS NS
CK = creatine kinase: Persist. ~ persistent ST elevation; SK = streptokinase; ST i -r- ST segment elevation.
so; probability values are considered significant when less
than 0,05,
Results
Clinical information (Table 1). All patients presented
with prolonged chest pain and hyperacute changes in the
electrocardiogram, indicative of ongoing myocardial in-
farction. Patients I to 9 (group I) received streptokinase
therapy within less than I hour of the onset of symptoms,
Of this group, Patients I to 4, with unstable angina, were
already hospitalized in the intermediate coronary care unit
or internal medicine department. The onset of severe chest
pain with acute injury pattern on electrocardiogram was
promptly noted by the medical staff, and when no response
was obtained from the administration of sublingual nitrates
and nifedipine, streptokinase infusion was begun before
transfer of the patient to the coronary care unit. These factors
allowed minimal delay in the onset of streptokinase therapy
after the mandatory time limit of at least 15 minutes of
unresolving chest pain as required by the protocol.
Patients /0 to /6 (group 1/) were treated within 2 to 3
hours of the onset of symptoms, For all patients except
Patient 6 in group I and Patient 16 in group II this was a
first myocardial infarction. Both Patients 6 and 16 had a
previous history of typical chest pain and serum enzyme
rise, Patient 6 had Q waves in the anteroseptal electrocar-
diographic leads; Patient 16had Qwaves in the lateral leads.
Chest pain ceased within 15 to 60 minutes after infusion of
streptokinase in both groups, and there was little need for
the further administration of analgesics, Accelerated idio-
ventricular rhythm was recorded within I to 3 hours after
streptokinase therapy in three of the nine patients in group
I and in four of the seven in group II. Episodes of sustained
ventricular tachycardia or ventricular fibrillation were not
observed in any of the patients and, after effective dilation
by percutaneousangioplasty, no further rhythmdisturbances
wereobserved. Noneof the patients showed signs of conges-
tive heart failure or ongoing ischemia.
Serum enzyme changes (Table 2). Serum creatine ki-
nase levels were normal (male < 120 mU/ml and female
< 110 mU/ml) in the first blood sample taken from all pa-
tients in both groups I and II. The levels subsequently in-
creased in all patients. Mean peak creatine kinase was
521 ± 284 mU/ml was in group I and 1,613 ± 709 mU/ml
in group II (Fig. I). This difference was significant (p <
0,05). Time from onset of symptoms to peak creatine kinase
was 7.1 ± 2,8 hours in group I and 10,2 ± 2,5 hours in
group II (p = NS).
Electrocardiographic information (Table 2). Persist-
ent ST segmentelevation in leads II, III and aVF wasdefined
as inferior wall infarction; in leads V I to V(, as anteroseptal
or anterior wall infarction; and in leads I and aVL as lateral
wall infarction, In five patients of group I and two patients
of group II the site of infarction was inferior. An anterior
or anteroseptal infarction was observed in four patients in
JACe Vol. Y. No 3
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Figure I. Mean peak creatine kinase (CK) was 521 ± 2g9 ml.l /rnl
in nine group I patients who received intravenous streptokinase
within 1 hour of the onset of chest pain. and 1.61 4 ± 709 mU/ml
in seven group II patients receiving therapy 2 10 J hours after the
onset of pain. The difference is significant (p <' 0.05).
group I and three in group II. Lateral wall infarction was
documented in two patients in group II. ST segment ele-
vation in the " infarct" leads and reciprocal changes returned
to isoelectric baseline in 3.0 :±: 1.5 and 4.8 ± 3.6 hours
in groups I and II. respectively (p = NS). In group I. new
Q waves developed in three patients (Patients I , 4 and 7)
and poor R wave progression in the anteroseptal leads in
Patient 3. In Patients 2, 5. 8 and 9 (group I) the electro-
cardiographic injury pattern returned to normal within a few
hours; Q waves did not develop in these patients despite a
marked rise in the creatine kinase levels. Every patient in
group II (Patients 10 to 16) developed new Q waves.
Cardiac catheterization and angioplasty (Table 3). The
infarct-related artery in Patients 2.3.6.8.11 and 14. who had
anterior wall myocardial infarction, was the left anterior
descending coronary artery; the artery was stenosed in either
its proximal or mid-portion. Patients IA.7.9.I Oand 12 pre-
sented with inferior wall infarction and showed high grade
right coronary artery stenosis. Patients 5. 13 and 15 had left
circumflex artery disease. All patients underwent successful
angioplasty of the infarct-related artery. Technically. the
stenoses were easily dilated and good forward flow was
obtained. Whenever multiple stenoses were noted in the
infarct-related artery. an attempt was made to dilate all
significant stenoses; no attempt was made to dilate stenoses
of other arteries.
Radionuclide studies (Table 3). Mean global ejection
fraction after streptokinase therapy was 47 :±: II % in group
I and 37 :±: 10% in group II (p < 0.05). At the second
study (after angioplastyand 7 days later) the ejection fraction
rose significantly to 53 :±: 9%- in group I (p < 0.05), and
40 :±: 70/£ in group II (p = NS). Patients 2,5.8 and 9 (group
\) showed no regional wall motion abnormalities and had a
normal ejection fraction at the first study. Patients 1.4 and
6. who had right coronary artery lesions. showed normal-
ization of inferoapical segmental hypokinesia in the second
study. Patient 3 had persistent mild hypokinesia of the septal
and inferoapical segments, with the proximal left anterior
descending artery being the infarct vessel. Seven of the nine
patients in group I had a normal ejection fraction and wall
motion at discharge. Patients 10.15 and 16(group II) showed
no change in regional wall motion between the two studies.
Only Patient 10 had a normal ejection fraction in both stud-
ies. but the regional wall motion abnormality persisted. and
no patients in group II had normal wall motion at discharge.
Three patients in each group underwent a third radionuclide
study after 3 to 6 months of discharge. No further improve-
ment in myocardial function was demonstrated.
Exercise testing. Eight of the nine patients in group I
(all except Patient 6) and fi ve of the seven patients in group
II (all except Patients I() and 15) performed a symptom-
limited treadmill exercise test before discharge. All reached
at least stage III (9 minutes) of the Bruce protocol (14) and
a maximal heart rate within 90ck of predicted maximal rate.
No symptoms or electrocardiographic ischemic changes were
noted.
Discussion
In this report we present our experience in the treatment
of two groups of patients with acute myocardial infarction.
Both groups completed identical treatment protocols, Group
I (nine patients) received intravenous streptokinase in less
than 1 hour. and group II (seven patients) within 2 to 3
hours from the onset of symptoms; both groups completed
identical treatment protocols. The essential difference was
the duration of symptoms before initiation of thrombolytic
therapy.
Duration of ischemia. Our results support prior obser-
vations that successful myocardial salvage is critically de-
pendent on the duration of ischemia, and that angioplasty
performed immediately thereafter may promote this im-
provement. Experimental studies (15. 16) suggest that the
effectiveness of coronary reperfusion in limiting the extent
of myocardial damage is determined by the amount of re-
sidual ischemic but still viable myocardium. The extent of
viable myocardium depends on the time interval from the
onset of coronary occlusion to revascularization. According
to Reimer et al. (17), more than SOCk of jeopardized isch-
emic myocardium in a dog model becomes necrotic within
:I hours after the onset of coronary occlusion. However. the
time course of transmural infarction in patients is unknown
and probably varies from patient to patient. Moreover. dis-
agreement exists as to the exact point where irreversibility
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Table 3. Radionuclide and Angiographic Findings
LVEF Radionuclide Wall Motion Ck Stenosis
Case II MUGA I MUGA II Coronary Anatomy Before PTCA After PTCA
Group I
43 50 MH, inf-ap Normal Distal RCA, 95 40
mid RCA 75 30
2 53 58 Normal Normal Mid LAD 99 20
3 40 46 MH, septal :!- MH-septal + Prox LAD 99 30
inf-ap inf-ap
4 43 52 MH, inf-ap Normal Mid RCA, 99 30
distal RCA, 75 10
prox II marginal 70
5 55 58 Normal Normal Prox LCx, 99 55
2nd diagonal 90
6 24 34 SH, ant-lat + MH ant-lat. Mid LAD. 90 20
inf-ap SH inf-ap distal LAD 50
7 53 55 MH, inf-ap Normal Mid RCA 85 15
8 61 66 Normal Normal Prox LAD 90 15
9 55 59 Normal Normal Mid RCA 90 40
Mean + SD 47 -T II 53 't 9 4 of 9 7 of 9 90 ± 9 27.:':' 13
P < 0.05 Normal wall motion p < 0.Cl2
Group II
10 52 50 MH, inf-ap MH, inf-ap Prox RCA 40 0
distal RCA 99 40
II 30 33 SH, ant-ap: SH. ant-up; Prox LAD 75 20
D, apex D, apex distal LAD 90
distal LCx 90
12 40 46 MH, inf-ap; MH, inf-ap; Prox RCA 99 40
SH,RV SH,RV
13 22 32 MH, inf-ap, MH. inf-ap, Prox large 90 30
lateral lateral Ist marginal
14 42 47 MH. septum; MH, septum; Mid-LAD 95 30
A, inf-ap A, inf-ap
15 44 44 MH, post-lat. MH, post-lat. Distal LCx 90 40
MH, inf-ap MH. inf-ap
16 32 33 SH, ant-tat: SH. ant-lat. Mid-LAD, 90 10
D, inf-ap D, inf-ap mid-RCA 60
Mean ± SD 37 ± 10 41 ± 8 001' 7 001' 7 85 .:±: 20 25 +c 15
p = NS Normal wall motion p < 0.05
A - akinesia; ant-ap ~ anteroapical; ant-lat anterolateral; D = dyskinesia; mf-ap = interoapical; LAD = left anterior descending coronary
artery; LCx = left circumflex coronary artery; LVEF - left ventricular ejection traction; MH = mild hypokinesia; MUGA = multigated aquisition:
post-tat = posterolateral; prox = proximal; PTCA = percutaneous transluminal coronary angioplasty; RCA = right coronary artery; RV right ven-
tricle; SH ~ severe hypokinesia; other abbreviations as before.
of myocardial damage occurs (18). More recent studies of
reperfusion by streptokinase, urokinase or tissue plasmin-
ogen activator, showed various time intervals as critical for
the efficacy of reperfusion therapy, Rentrop et al. (5) defined
4 hours as a critical delay while Mathey et al. (7) found
improvement in left ventricular function only when the delay
was less than 2 hours. Koren et al. (8) found 1.5 hours of
ischemia to be critical, thus suggesting that streptokinase
should be administered by the mobile coronary care unit
team, provided that an experienced physician is part of the
team. In our patients streptokinase therapy was initiated in
the hospital, frequently in the emergency room, before trans-
fer of the patient to the intensive coronary care unit.
Left ventricular function. In our study, the earlier re-
perfusion in patients in group I resulted in a higher global
ejection fraction in their initial postreperfusion study as com-
pared with that in group II. In group I there was a significant
global ejection fraction increase. Seven (78o/c) of the nine
patients in group I were discharged with a normal ejection
fraction and regional wall motion, as opposed to abnor-
malities in regional wall motion in all patients in group II
and significantly depressed ejection fractions in six of the
seven patients.
Timing of streptokinase administration. Infusion of
streptokinase in the first nine patients was instituted in a
shorter time (less than I hour) than in earlier reports. It
JACC Vol 'i. No.3
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appears that by very early reperfusion, tissue is being sal-
vaged and "stunning" is prevented. This conclusion is cor-
roborated by the marked improvement in wall motion ab-
normalities that was demonstrated within less than 10 days
in our group I. Non-Q wave infarction was observed only
in two patients from the very early treatment group. Koren
et al. (8) also reported that of the eight patients in their
group with non-Q wave infarction, six received treatment
in less than 1.5 hours. Their patients, similar to ours, had
a higher ejection fraction and lower peak creatine kinase
level. Ganz et al. (I) observed that in 43 patients in whom
thrombolysis was successful, left ventricular ejection frac-
tion increased significantly, whereas in patients whose in-
farct-related artery remained occluded or who did not undergo
intracoronary thrombolysis, there was no improvement in
function.
Serum enzyme values. Peak creatine kinase, which re-
fleers the extent of myocardial damage, was substantially
lower in group I than in group II, thus indicating a lesser
degree of myocardial cellular damage. In all patients except
Patient 2, peak creatine kinase level was greater than twice
the normal level (120 rnl.l/ml), suggesting the presence of
ongoing muscle necrosis and not transient ischemia. Ac-
cording to Garizet al. (I) creatine kinase activity and release
may be two to three times higher after reperfusion than is
usually observed during myocardial infarction. Peak crea-
tine kinase activity in their study occurred within 4 to 12
hours. Our results are similar in that the peak was earlier
and smaller in patients treated within less than I hour.
Other determinants of myocardial salvage. In addition
to the duration of symptoms, the presence of collateral ves-
sels and subtotal coronary occlusion are two other important
determinants of myocardial salvage. However, according to
Mathey et al, (7), the latter two factors cannot explain the
good recovery in wall motion in patients treated within 2
hours of the onset of symptoms. Their experience, as well
as that of others (2), supports the role of early reperfusion
in achieving a greater improvement in global left ventricular
ejection fraction, or a smaller infarct area in these patients.
DeWood et al, (19) suggested that enhancement of global
function and regional wall motion occurs in selected patients
if surgical reperfusion is performed within 6 hours of the
onset of anterior infarction. Their data support the concept
that the hypercontractile changes occurring in some patients
in contralateral segments of the ventricle are primarily re-
sponsible for inconsistent correlation between regional and
global function during early anterior infarction.
Coronary angioplasty after thrombolysis. The relative
importance of the early coronary angioplasty after reper-
fusion by streptokinase in promoting myocardial recovery
is not entirely clear. Topol et al. (10) demonstrated that
angioplasty after successful thrombolysis of an acute coro-
nary occlusion has an important role in further improving
regional function. This is also the experience of other centers
(20,21). All our patients had successful angioplasty of crit-
ical stenoses in their infarct arteries. In none of our patients
was there clinical evidence of restenosis or angina during
hospitalization after angioplasty. Theoretically, early re-
perfusion may reduce mortality by preserving a critical mass
of myocardium and, by preventing progression of necrosis,
improve tissue healing processes. Both groups of our pa-
tients showed promising exercise capacity when undergoing
treadmill exercise testing before discharge, indicative of
preserved left ventricuiar function and absence of significant
ischemia.
Conclusions. The results of our study emphasize the
critical importance of early thrombolytic therapy followed
by angioplasty in the course of myocardial infarction to
ensure adequate reperfusion of the infarcted segment. Every
measure that shortens the delay in the patient's seeking
medical advice will reduce the time to thrombolytic therapy
and subsequent angioplasty. This may result in decreased
infarct size and better preservation of left ventricular func-
tion.
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